TransCode Therapeutics - SEC Filing
Por um escritor misterioso
Descrição
TransCode Therapeutics - SEC Filing
RNAZ - TransCode Therapeutics Announces Pricing of $8 Million
TransCode Therapeutics Manhattan Street Capital
EDGAR Filing Documents for 0001104659-21-029169
Dominic Vacchiano on LinkedIn: 🧬 Biopharma insight for → Data
EDGAR Filing Documents for 0001104659-21-029169
IPO Update: TransCode Therapeutics Pursues $25 Million IPO
EDGAR Filing Documents for 0001104659-21-029169
tm2038085-5_s1 - none - 15.3906315s
TransCode Therapeutics - Investor Relations
de
por adulto (o preço varia de acordo com o tamanho do grupo)
